Corpus Intelligence DCF — CALLAHAN EYE FOUNDATION HOSP 2026-04-26 02:08 UTC
DCF — CALLAHAN EYE FOUNDATION HOSP
Enterprise Value: $-11.1M
🛡️ Public data only — no PHI permitted on this instance.
$-11.1M
Enterprise Value
$-5.9M
PV of Cash Flows
$-5.2M
PV of Terminal Value
$-8.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth

Cash Flow Projections

PROJ
YearRevenueEBITDAMarginFCFPV(FCF)
Year 1$95.2M$1.2M1.0%$-2.8M$-2.5M
Year 2$98.1M$2.2M2.0%$-1.9M$-1.6M
Year 3$101.0M$3.3M3.0%$-1.1M$-0.9M
Year 4$104.0M$3.9M4.0%$-0.8M$-0.5M
Year 5$107.2M$4.3M4.0%$-0.6M$-0.4M

Interpretation

INT

At a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-11.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.

Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.

Assumptions

ASSM
revenue base$92.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.00793874295297723
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5